Enhancing PD-L1 Degradation by ITCH during MAPK Inhibitor Therapy Suppresses Acquired Resistance
Related Posts
Armstrong A, González-Cantero A, Khattri S, Muzy G, Malatestinic WN, Lampropoulou A, Feely M, See SK, Mert C, Blauvelt A. Comparing Achievement of National Psoriasis[...]
Peterson H, Huang MY, Lee K, Kingston P, Yee D, Korouri E, Agüero R, Armstrong AW. Comorbidity Burden in Psoriasis Patients with Skin of Color.[...]
Noveir SD, Wu J, Langevin KK. Sustained improvement of elastosis perforans serpiginosa after isotretinoin therapy. JAAD Case Rep. 2024 Feb 19;46:23-26. doi: 10.1016/j.jdcr.2024.02.006. PMID: 38510841;[...]